Moderna Inc's vaccine against Covid-19 could be ready for widespread use by the end of this year, US and company officials said on Monday, after the drugmaker announced the start of a 30 000-subject trial to demonstrate it is safe and effective, the final hurdle prior to regulatory approval.
More than 150 coronavirus vaccine candidates are in various stages of development, with some two dozen prospects already conducting human testing. Manufacturers are ramping up production while testing is underway in order to respond as soon as possible to virus, which is still spreading rapidly around the world. Covid-19 has killed nearly 650,000 people worldwide and battered economies.
The large late-stage trial is designed to evaluate the safety of Moderna's mRNA-1273 vaccine and determine if it can prevent symptomatic Covid-19 after two doses.
Source: Law Daily Report (lawdailyreport.net)
South Africa Latest News, South Africa Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: dailymaverick - 🏆 3. / 84 Read more »
Source: dailymaverick - 🏆 3. / 84 Read more »
Source: eNCA - 🏆 49. / 51 Read more »
India is on the hunt for plasma to beat Covid-19India, the world's biggest suppliers of generic drugs, is scrambling to end a local shortage of remdesivir and tocilizumab
Source: BDliveSA - 🏆 12. / 63 Read more »
DJ Euphonik on performing in Europe post Covid-19'So coming to Europe, was me trying to salvage the bit of 2020 that I could ... Here we are able to move around, still under strict conditions, and hustle a bit, while doing some promo work and marketing ourselves to the world.”
Source: TimesLIVE - 🏆 28. / 59 Read more »
COVID-19 LIVE UPDATES | Ramaphosa confident SA has 'ingredients for economic recovery' as virus wreaks havoc'This is not the time to despair but to act. It is untenable, and unacceptable, to live with an unemployment rate of 30 percent, which will soon increase. It is also impossible to build an economy built on inequality.'
Source: TimesLIVE - 🏆 28. / 59 Read more »